California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
